Ginkgo Bioworks Holdings Inc vs Pinterest Inc — how do they compare? Ginkgo Bioworks Holdings Inc trades at $13 (market cap $763.64M), while Pinterest Inc trades at $21.4 (market cap $11.63B). The key difference: Pinterest Inc is far larger — about 15.2× Ginkgo Bioworks Holdings Inc's market cap, and Ginkgo Bioworks Holdings Inc is trading nearer its 52-week high, Pinterest Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Ginkgo Bioworks Holdings Inc for 7 Days and Pinterest Inc for 85 Days on average.
| DNA | PINS | |
|---|---|---|
Market Cap | $763.64M | $11.63B |
Volume | 3,204,177 | 12,792,940 |
Sector | Health | Media |
52-Week High | $15.83 | $35.24 |
52-Week Low | $5.48 | $15.42 |
Typical Hold Time | 7 Days | 85 Days |
Enterprise Value | $865.59M | $11.55B |
Signals from Pluang's Aura AI — not financial advice
Ginkgo Bioworks (DNA) trades at $13.00, up 13.34% today, with a bullish technical signal from moving averages. The company shows strong gross margins of 68.04% but remains unprofitable with a -219.6% net margin. Recent news includes a $17.5M ARPA-H subcontract for RNA medicine manufacturing and partnership expansions, though revenue declined to $132M in 2026.
DNA presents high risk with significant losses and cash burn, but analyst sentiment is divided with equal buy/sell ratings. Investment appeal hinges on future profitability from recent partnerships and government contracts, while current financials and negative cash flow pose substantial downside risk.
Pinterest (PINS) trades at $20.525, up 1.06% with a bullish technical signal despite mixed oscillators. The company demonstrates strong revenue growth from $2.8B in 2022 to $4.2B in 2025, with consistent earnings beats in recent quarters. Analyst consensus is strongly positive with 54% buy ratings and a $27.93 price target, representing 36% upside potential from current levels.
PINS offers compelling growth potential driven by international monetization and visual search advertising innovations, though elevated valuation metrics (P/E 60.38) and insider selling activity warrant caution. The stock's primary catalysts include continued user growth and advertising revenue expansion, while risks center on competitive pressure and execution challenges in global markets.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →Pinterest is an online product and idea discovery platform that helps users gather ideas on everything from recipes to cook to destinations to travel to. Founded in 2010, the platform consists of a largely female audience, at roughly two thirds of its more than 365 million monthly active users. The company generates revenue by selling digital ads and is now rolling out more in-platform e-commerce features.
Read more on PINS →